Found: 237
Select item for more details and to access through your institution.
Effect of sacubitril-valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1366035
- By:
- Publication type:
- Article
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0
- By:
- Publication type:
- Article
Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly?
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3056, doi. 10.3390/jcm13113056
- By:
- Publication type:
- Article
Effect of Sacubitril/Valsartan on Patients Having Heart Failure With Preserved Left Ventricular Ejection Fraction Undergoing Hemodialysis: A Long-term Observational Study.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1266, doi. 10.21873/invivo.13564
- By:
- Publication type:
- Article
Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1357673
- By:
- Publication type:
- Article
Effectiveness and Safety of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
- Published in:
- Alternative Therapies in Health & Medicine, 2024, v. 30, n. 4, p. 190
- By:
- Publication type:
- Article
Influence of Aging on Outcomes of Sacubitril/Valsartan in Hypertensive Patients with Heart Failure: A Multicenter Retrospective Study.
- Published in:
- Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2024, v. 28, n. 4, p. 194, doi. 10.14744/AnatolJCardiol.2023.3857
- By:
- Publication type:
- Article
Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 733, doi. 10.3390/biomedicines12040733
- By:
- Publication type:
- Article
The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse Model.
- Published in:
- Inflammation, 2024, v. 47, n. 2, p. 696, doi. 10.1007/s10753-023-01939-7
- By:
- Publication type:
- Article
Bilanz Novartis 2023: Fürs Herz und gegen Krebs.
- Published in:
- Nachrichten aus der Chemie, 2024, v. 72, n. 4, p. 41, doi. 10.1002/nadc.20244140771
- By:
- Publication type:
- Article
The Efficacy and Safety of Sacubitril/Valsartan Compared to Valsartan in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fractions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1572, doi. 10.3390/jcm13061572
- By:
- Publication type:
- Article
Correction to: Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
From statistical inference to machine learning: A paradigm shift in contemporary cardiovascular pharmacotherapy.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 3, p. 691, doi. 10.1111/bcp.15927
- By:
- Publication type:
- Article
Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization.
- Published in:
- Cardiology & Therapy, 2024, v. 13, n. 1, p. 149, doi. 10.1007/s40119-023-00346-1
- By:
- Publication type:
- Article
Patients with heart failure and reduced ejection fraction after sacubitril/valsartan treatment may be at risk for major adverse cardiovascular events according to ΔRDW.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2024, v. 15, n. 3, p. 602
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study.
- Published in:
- Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02051-x
- By:
- Publication type:
- Article
Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease.
- Published in:
- Diabetology & Metabolic Syndrome, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13098-024-01284-1
- By:
- Publication type:
- Article
Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0295226
- By:
- Publication type:
- Article
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure.
- Published in:
- Heart & Vessels, 2024, v. 39, n. 2, p. 95, doi. 10.1007/s00380-023-02311-3
- By:
- Publication type:
- Article
Comparative renoprotection: Sacubitril/valsartan versus ACEI or ARB - A systematic review and meta-analysis.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2024, v. 23, n. 2, p. 447, doi. 10.4314/tjpr.v23i2.27
- By:
- Publication type:
- Article
Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study.
- Published in:
- BMC Cardiovascular Disorders, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12872-024-03744-y
- By:
- Publication type:
- Article
Knowledge domain and emerging trends in sacubitril/valsartan study from 2008 to 2023 -- a visualized conclusive analysis based on novel scientometric tools.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 2, p. 502
- By:
- Publication type:
- Article
Comparison of the efficacy of combining left bundle branch pacing with either sacubitril/valsartan or enalapril in the treatment of chronic heart failure: A retrospective observational analysis.
- Published in:
- Pakistan Journal of Medical Sciences, 2024, v. 40, n. 3, Part 2, p. 265, doi. 10.12669/pjms.40.3.8520
- By:
- Publication type:
- Article
Decrease in Mycophenolic Acid Plasma Level by Sacubitril/Valsartan in a Lupus Nephritis Patient: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Association Between Albumin-Bilirubin Score and Ventricular Arrhythmia in Patients with Heart Failure.
- Published in:
- E Journal of Cardiovascular Medicine, 2024, v. 12, n. 1, p. 17, doi. 10.32596/ejcm.galenos.2024.2024-6-60
- By:
- Publication type:
- Article
Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Investigation of the efficacy of beta-blockers and renin-angiotensin-aldosterone system inhibitors in chronic heart failure with preserved ejection fraction.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2024, v. 23, n. 1, p. 175, doi. 10.4314/tjpr.v23i1.22
- By:
- Publication type:
- Article
Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 12, p. 643, doi. 10.1093/ajh/hpad075
- By:
- Publication type:
- Article
Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 4, p. 397, doi. 10.1007/s40268-023-00438-2
- By:
- Publication type:
- Article
ΔRDW Could Predict Major Adverse Cardiovascular Events in Patients with Heart Failure with Reduced Ejection Fraction After Sacubitril/Valsartan Treatment.
- Published in:
- International Journal of General Medicine, 2023, v. 16, p. 5989, doi. 10.2147/IJGM.S444585
- By:
- Publication type:
- Article
Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy.
- Published in:
- Molecular & Cellular Biochemistry, 2023, v. 478, n. 12, p. 2645, doi. 10.1007/s11010-023-04690-7
- By:
- Publication type:
- Article
The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension.
- Published in:
- Heart & Vessels, 2023, v. 38, n. 11, p. 1337, doi. 10.1007/s00380-023-02283-4
- By:
- Publication type:
- Article
Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan among Patients with Heart Failure.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2568, doi. 10.3390/pharmaceutics15112568
- By:
- Publication type:
- Article
Study on the Efficacy of Sacubitril/Valsartan in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Peritoneal Dialysis.
- Published in:
- Cardiology, 2023, v. 148, n. 5, p. 385, doi. 10.1159/000531217
- By:
- Publication type:
- Article
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience.
- Published in:
- Clinics & Practice, 2023, v. 13, n. 5, p. 1015, doi. 10.3390/clinpract13050090
- By:
- Publication type:
- Article
Incidence of atrial and ventricular arrhythmias in obese patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2999, doi. 10.1111/dom.15198
- By:
- Publication type:
- Article
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6247, doi. 10.3390/jcm12196247
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291754
- By:
- Publication type:
- Article
Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 9, p. 1237, doi. 10.1093/jpp/rgad049
- By:
- Publication type:
- Article
Successful Use of Angiotensin Receptor-Neprilysin Inhibitor along with Intravenous Inotropes, in a Postcardiac Surgery Child with an Anomalous Left Coronary Artery from the Pulmonary Artery Repair.
- Published in:
- Journal of the Practice of Cardiovascular Sciences, 2023, v. 9, n. 3, p. 206, doi. 10.4103/jpcs.jpcs_61_23
- By:
- Publication type:
- Article
沙库巴曲缬沙坦钠对老年慢性心力衰竭合并2型糖尿病患者肾功能、神经内分泌激素和TGF-β1/Smad3信号通路的影响.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 16, p. 3102, doi. 10.13241/j.cnki.pmb.2023.16.020
- By:
- Publication type:
- Article
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2982, doi. 10.1093/eurheartj/ehad344
- By:
- Publication type:
- Article
Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Efficacy and Safety of Sacubitril/Valsartan Compared With ACEI/ARB on Health-Related Quality of Life in Heart Failure Patients: A Meta-Analysis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 907, doi. 10.1177/10600280221140575
- By:
- Publication type:
- Article
Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 15, p. 7264
- By:
- Publication type:
- Article
Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1780, doi. 10.1093/ndt/gfad066
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in peritoneal dialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1880, doi. 10.1093/ndt/gfad038
- By:
- Publication type:
- Article
LCZ696 Ameliorates Tachycardia-Induced Cardiac Calcium Dyshomeostasis in the SERCA2α-Dependent Pathway.
- Published in:
- Tohoku Journal of Experimental Medicine, 2023, v. 260, n. 4, p. 315, doi. 10.1620/tjem.2023.J043
- By:
- Publication type:
- Article